Famodar Brand names, Famodar Analogs
Famodar Brand Names Mixture
Famodar fda sheet
Famodar msds (material safety sheet)
Famodar Synthesis Reference
H. Yasufumi et al.; U.S. Pat. 4,283,408 (1981)
Famodar Molecular Weight
Famodar Melting Point
Famodar H2O Solubility
Famodar Dosage Forms
Oral tablets; Rapid disintergrating tablets; Suspension; Injectable solution
For the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD).
Famotidine, a competitive histamine H2-receptor antagonist, is used to treat gastrointestinal disorders such as gastric or duodenal ulcer, gastroesophageal reflux disease, and pathological hypersecretory conditions. Famotidine inhibits many of the isoenzymes of the hepatic CYP450 enzyme system. Other actions of Famotidine include an increase in gastric bacterial flora such as nitrate-reducing organisms.
The bioavailability of oral doses is 40-45%.
Famodar side effects and Toxicity
Intravenous, mouse: LD50 = 244.4mg/kg; Oral, mouse: LD50 = 4686 mg/kg. Symptoms of overdose include emesis, restlessness, pallor of mucous membranes or redness of mouth and ears, hypotension, tachycardia and collapse.
Famodar Patient Information
Famotidine is used to treat stomach and duodenal (upper small intestine) ulcers;
hypersecretory (increased acid secretion) conditions; heartburn and gastroesophageal
reflux disease (stomach contents bubbling into the esophagus causing pain). Notify your
physician if you are pregnant or nursing. Famotidine may be taken with or without food.
Shake the oral suspension vigorously for 5-10 seconds before taking. Unused oral
suspension should be discarded after 30 days. Notify your physician if you develop black,
tarry stools or coffee-ground vomit.
Famodar Organisms Affected
Humans and other mammals